Invesco Mortgage Capital (IVR) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Focuses on investing in, financing, and managing mortgage-backed securities (MBS) and other mortgage-related assets, including agency and non-agency RMBS and CMBS.
Operates as a REIT, aiming to provide attractive risk-adjusted returns primarily through dividends.
Externally managed by Invesco Advisers, Inc., a subsidiary of Invesco Ltd.
Finances investments mainly through short-term repurchase agreements, with additional financing from debt and equity issuances.
Maintains REIT status by distributing at least 90% of taxable income annually and adhering to ownership and transfer restrictions.
Financial performance and metrics
Registration statement incorporates by reference the Annual Report on Form 10-K for the year ended December 31, 2023, and subsequent quarterly reports.
Financial statements audited by PricewaterhouseCoopers LLP.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used for new investments, debt repayment, or general corporate purposes, with specific allocations to be detailed in future prospectus supplements.
Latest events from Invesco Mortgage Capital
- Director elections, executive pay, and auditor ratification up for vote at the 2026 annual meeting.IVR
Proxy filing20 Mar 2026 - Board refreshment, strong returns, and robust governance highlight this year's proxy agenda.IVR
Proxy filing20 Mar 2026 - Book value per share rose 3.7% to $8.72, with an 8.0% economic return and higher dividend.IVR
Q4 20252 Feb 2026 - Book value per share fell 8% in Q2, but distributable earnings and dividend remained stable.IVR
Q2 20241 Feb 2026 - Q3 2024 saw a return to profitability, higher book value, and a 5.4% economic return.IVR
Q3 202416 Jan 2026 - Book value dropped 4.8% in Q4, with net loss and improved capital structure amid volatility.IVR
Q4 202423 Dec 2025 - Board seeks approval for director elections, executive pay, and auditor ratification amid strong governance.IVR
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification up for vote at May 2025 meeting.IVR
Proxy Filing1 Dec 2025 - Earnings rebounded in Q1 2025, but book value fell as volatility and risks persisted.IVR
Q1 202525 Nov 2025